CAT Grants - Cornell University fund Cornell researchers’ collaborations with New York State companies to advance early-stage life science technologies toward commercialization and measurable economic impact.
Funder: Cornell University
Due Dates: September 1, 2026 (Applications open) | October 30, 2026 at 5 p.m. (Application deadline) | January 1, 2027 (Project start)
Funding Amounts: Generally around $50,000 in matching funds; an additional $5,000 available for qualifying materials research
Summary: Supports Cornell–New York State company collaborations advancing early-stage life science technologies toward commercialization and measurable economic impact.
Key Information: An eligible Cornell principal investigator must partner with a New York State for-profit company providing cash support.
Cornell’s CAT Grants are a competitive program supporting early-stage life science technologies as they move toward commercialization. The grants are administered by the Center for Life Science Enterprise, a designated Center for Advanced Technology hosted by the Cornell Institute of Biotechnology. The program connects Cornell researchers with New York State companies to develop life science technology products aimed at the market.
The program encourages innovative biotechnology projects with potential future industry interest and quantifiable economic impact in New York State. Supported fields include bioengineering, diagnostic and detection technologies, medical devices, therapeutics, animal health, and agriculture. Faculty applicants are encouraged to prepare proposals collaboratively with their industrial partners. Projects using Cornell’s Biotechnology Resource Center (BRC) core facilities are especially welcome.